I am hoping someone out there has had an epiphany on how to handle "STAT" drugs that are straight draws, like fosphenytoin and oxytocin, with USP 800 regulations. If you are allowing the nurse to draw them up, how are you documenting that in your Assessment of Risk? If you are having pharmacy draw them up, how are you communicating that with OB, Neuro, ED, etc?
Over half of our 13 hospitals have non-24 hour pharmacies. We are trying to figure out how to have a consistent process in all hospitals at all times...which we realize is a tall order.
We are struggling with weighing timely patient care vs nursing protection from hazardous drugs.
Thanks so much for any and all insight!
Karin Terry
OSF HealthCare
Peoria, IL